Gateway Advisory’s Ionis Pharmaceuticals IONS Stock Holding History

Gateway Advisory’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,000	Closed	-$248K	–	43
2015 Q4	$248K	Buy	+4,000	New	+$216K	0.11%	40
2015 Q1	–	Sell	-4,000	Closed	-$247K	–	41
2014 Q4	$247K	Buy	+4,000	New	+$197K	0.11%	33
2014 Q3	–	Sell	-6,750	Closed	-$233K	–	40
2014 Q2	$233K	Buy	+6,750	New	+$213K	0.11%	38
2013 Q3	–	Sell	-12,500	Closed	-$336K	–	30
2013 Q2	$336K	Buy	+12,500	New	+$266K	0.2%	31

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Gateway Advisory's IONS Position: Q1 2016 in Review

Gateway Advisory sold out of Ionis Pharmaceuticals (IONS) in Q1 2016, closing a stake of 4,000 shares — an estimated $248K sold.

Gateway Advisory first reported a position in IONS in Q2 2013 and held it in 4 quarters. The position peaked at $336K in Q2 2013. 314 funds tracked by Wall St. Rank hold IONS as of Q1 2016.

Gateway Advisory reported no remaining Ionis Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Gateway Advisory sold 4,000 Ionis Pharmaceuticals shares in Q1 2016, an estimated $248K.
Gateway Advisory first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 4 quarters.
Gateway Advisory's Ionis Pharmaceuticals position peaked at $336K in Q2 2013.
314 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2016.

Based on Gateway Advisory's 13F filing for Q1 2016, filed 10 May 2016.